ad image

Positive Recommendation

1 / 1
Soligenix, Inc.
Phase 3

Soligenix Announces Positive Recommendation by Independent Data Monitoring Committee on its Phase 3 Clinical Trial of SGX301

Soligenix, Inc.

PR-M10-18-NI-054Oct 16, 2018
1 / 1